XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Balance, beginning of the period at Dec. 31, 2017 $ 3,358 $ 12,800 $ 127,431 $ (1,887)   $ 141,702
Comprehensive income:            
Net income (loss)     8,962     8,962
Other comprehensive income/(loss)       (2,310)   (2,310)
Share-based compensation   640       640
Restricted stock vested 15 (15)        
Common stock issued 1 71       72
Common stock purchased (4) (228)       (232)
Cash dividends declared     (2,381)     (2,381)
Balance, end of period at Jun. 30, 2018 3,370 13,268 134,012 (4,197)   146,453
Balance, beginning of the period at Mar. 31, 2018 3,369 12,925 130,133 (3,728)   142,699
Comprehensive income:            
Net income (loss)     5,070     5,070
Other comprehensive income/(loss)       (469)   (469)
Share-based compensation   321       321
Restricted stock vested 1 (1)        
Common stock issued   36       36
Common stock purchased   (13)       (13)
Cash dividends declared     (1,191)     (1,191)
Balance, end of period at Jun. 30, 2018 3,370 13,268 134,012 (4,197)   146,453
Balance, beginning of the period at Dec. 31, 2018 3,358 12,752 140,520 (4,672)   151,958 [1]
Comprehensive income:            
Net income (loss)     9,614   $ (1) 9,613
Other comprehensive income/(loss)       2,552   2,552
Issuance of noncontrolling interest         490 490
Share-based compensation   767       767
Restricted stock vested 16 (16)        
Common stock issued 1 69       70
Common stock purchased (70) (3,465)       (3,535)
Cash dividends declared     (2,564)     (2,564)
Balance, end of period at Jun. 30, 2019 3,305 10,107 147,570 (2,120) 489 159,351
Balance, beginning of the period at Mar. 31, 2019 3,337 11,362 143,003 (3,292) 490 154,900
Comprehensive income:            
Net income (loss)     5,843   (1) 5,842
Other comprehensive income/(loss)       1,172   1,172
Share-based compensation   310       310
Restricted stock vested 1 (1)        
Common stock issued   34       34
Common stock purchased (33) (1,598)       (1,631)
Cash dividends declared     (1,276)     (1,276)
Balance, end of period at Jun. 30, 2019 $ 3,305 $ 10,107 $ 147,570 $ (2,120) $ 489 $ 159,351
[1] Derived from audited consolidated financial statements.